摘要
目的:探究对盆腔炎患者予以莫西沙星与替硝唑联合治疗的临床效果。方法:择取我院于2013年4月—2015年5月收治的盆腔炎患者84例,将其以随机抽样的方法进行分组研究,即分为实验组与对照组,各42例。对照组患者接受莫西沙星治疗,实验组在对照组的基础上联合使用替硝唑治疗,对比两组患者接受治疗后的临床效果、并发症的发生几率以及临床症状的消失时间。结果:实验组患者接受治疗后的总体有效率41例(97.62%)显著低于对照组30例(71.43%)。P<0.05,两组差异于统计学而言有意义。实验组患者发生不良反应的几率4例(9.52%)显著低于对照组12例(18.57%),P<0.05,两组差异于统计学而言有意义。实验组患者各项临床症状的消失时间均低于对照组,P<0.05,两组差异于统计学而言有意义。结论:对盆腔炎患者予以莫西沙星与替硝唑联合治疗具有较为显著的临床效果,能够有效提高生存质量以及康复效果,具有一定的安全性和有效性,可广泛用于临床治疗的过程中。
Objective:To explore the clinical effect of moxifloxacin combined with tinidazole in patients with pelvic inflammatory disease.Methods:84patients with pelvic inflammatory disease admitted in our hospital from April2013to May2015were randomly divided into experimental groupand control group(42cases).The patients in the control group were treated with moxifloxacin.The experimental group was treated with tinidazole inthe control group.The clinical effect,the occurrence of the complication and the disappearance time of the clinical symptoms were compared betweenthe two groups.Results:The total effective rate in the experimental group was significantly higher than that in the control group(97.63%)(P<0.05).The rate of adverse reactions was4cases(9.52%)in the experimental group and12cases(18.57%)in the control group(P<0.05).The disappearancetime of clinical symptoms in the experimental group was lower than that in the control group(P<0.05).Conclusion:Moxifloxacin combined withtinidazole in patients with pelvic inflammatory disease has a significant clinical effect,can effectively improve the quality of life and rehabilitationeffect,with a certain degree of safety and effectiveness.Thus,it should be widely used in the clinical treatment process.
作者
陶金兰
TAO Jin-lan(Maternal and child health care hospital of Fuzhou City, Jiangxi Province, Fuzhou Jiangxi 344000, China)
出处
《药品评价》
CAS
2017年第8期59-61,共3页
Drug Evaluation
关键词
莫西沙星联合替硝唑
盆腔炎
临床效果
护理方法
并发症
Moxifloxacin Combined with Tinidazole
Pelvic Inflammatory Disease
Clinical Effect
Nursing Methods
Complications
